Conéctate
Conéctate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Regístrate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Líderes empresariales

InicioTodasLas noticias más leídasBiografía de los líderes empresariales 
Portrait de Martin MacKay
Edad : 65
Patrimonio público : 9 104 106 USD
País de residencia : Desconocido
Principales empresas : Novo Nordisk A/S - Charles River Laboratories International, Inc. - Rallybio Corporation

Resumen 
Founder of Rallybio Corp. and Rallybio LLC, Martin W. MacKay is an American businessperson who has been at the head of 8 different companies and currently occupies the position of Chairman & Chief Executive Officer at Rallybio Corp., Chairman & Chief Executive Officer of Rallybio LLC and Chief Executive Officer & Director at Rallybio Holdings LLC (both are subsidiaries of Rallybio Corp.), Chief Executive Officer for Calyx Group Ltd. (Ireland) and Senior Advisor at New Leaf Venture Partners LLC.

He is also on the board of Charles River Laboratories International, Inc., Charles River Laboratories, Inc. and Novo Nordisk A.

In his past career Martin W. MacKay was Chief Executive Officer & Director at Neverfail, Inc. and Chief Executive Officer & Director at Neverfail Group Ltd. (a subsidiary of Neverfail, Inc.), Senior Vice President-Worldwide Development at Pfizer Inc. and President of Pfizer (St. Louis) (a subsidiary of Pfizer Inc.), President-Research & Development at AstraZeneca Plc and Global Head-Research & Development at Alexion Pharmaceuticals, Inc. (a subsidiary of AstraZeneca Plc), Vice President-International at VeriSign, Inc., Principal at PeopleSoft USA, Inc., Principal at Beecham Pharmaceuticals (UK), Chief Executive Officer for Vecta Software Corp. Ltd., Operations Director of The Dun & Bradstreet Corp., Head-Drug Preformulation & Delivery at BASF Performance Products Ltd. (United Kingdom), Head-Molecular & Cell Biology at CRI Worldwide LLC, Principal at Accenture LLC, Director-Business Development at NorthgateArinso, Inc. and Head-Drug Preformulation & Delivery at Ciba-Geigy Pharmaceuticals.

Dr. MacKay received an undergraduate degree from Heriot-Watt University and a doctorate from The University of Edinburgh.




Posiciones actuales de Martin MacKay 
Participaciones de Martin MacKay 
Martin MacKay : Red personal 
Noticias más leídas 
01/12Las acciones de Salesforce caen tras la sorpresiva salida del codirector general Taylor
MR
23/11Berkshire Hathaway dice que Warren Buffett dona acciones a organizaciones benéficas familiares
MR
30/11Zuckerberg, de Meta, dice que algunos de los planteamientos de contenido de Elon Musk en Twitter "podrían funcionar
MR
06/12El ascenso y la caída de Wirecard
MR
30/11La Juventus no tiene necesidad de capital adicional, dice Elkann de Exor
MR
29/11O'Leary, de Ryanair, dice que el sector es el más optimista en 25 años
MR
07/12El multimillonario Forrest quiere desarrollar 5 GW de parques eólicos para 2030
MR
02:26El consejero delegado de SoftBank, Son, eleva su participación en la empresa al 34% y se encamina hacia la compra - Bloomberg News
MR
29/11Prada contratará al ex director general de Luxottica, Guerra, para facilitar la sucesión - fuente
MR
07/12El Banco de Japón debe mantener una política ultralaxa, afirma Nakamura, miembro del consejo
MR
Más noticias


© 2022 People and Ownership :   
Martin MacKay Conexiones 


Últimas noticias acerca de Martin MacKay 
- Ningúna noticia -
Más noticias